<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01526863</url>
  </required_header>
  <id_info>
    <org_study_id>10.53.NRC</org_study_id>
    <nct_id>NCT01526863</nct_id>
  </id_info>
  <brief_title>Hydrolyzed Egg and Tolerance Induction</brief_title>
  <official_title>Assessment of the Effect of an HA Egg Administration for 6 Months on the Tolerance Induction to Egg in Children Allergic to Egg as Compared to a Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this trial is to assess the effect of hydrolyzed egg orally administered on oral
      tolerance induction to egg in children allergic to egg as compared to a placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>positive or negative result (objective and subjective symptoms) of a challenge test with egg</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>compliance (product taken)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>skin prick test (sensitization to egg; size of wheal and flare)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunological parameters: total and specific IgE and IgG4, cytokines, basophil activation</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity / Adverse Events</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Allergy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>HA egg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>HA egg</intervention_name>
    <description>Daily dose of HA egg or placebo for 6 months</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>HA egg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Child of any ethnicity aged between 12 and 66 months at the time of enrolment

               -  Positive Skin Prick Test (SPT) to egg white within the last 3 months

               -  Either positive oral challenge OR convincing history, defined as an immediate
                  (&lt;1h) reaction following isolated ingestion of egg, positive SPT to egg white and
                  positive sIgE (&gt; 0.35 kU/L) for at least one of the following: egg, egg white,
                  ovalbumin, ovomucoid, within the last 12 months

               -  Having obtained his/her signed legal representative's informed consent.

        Exclusion Criteria:

          -  History of severe anaphylaxis to egg

               -  Significant pre-natal and/or post-natal disease

               -  Child on systemic drugs (e.g. antihistamines, beta-agonists, ACE-inhibitors)
                  according to half-life at time of enrolment

               -  Congenital illness or malformation that may affect normal growth (especially
                  immunodeficiency)

               -  Child whose parents / caregivers cannot be expected to comply with treatment

               -  Child currently participating in another interventional clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>66 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nikolaos Papadopoulos, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Athens, Greece</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonella Muraro, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Padua, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Lauener, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hochgebirgsklinik Davos, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stavroula Giavi, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Athens, Greece</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Athens</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Padua</name>
      <address>
        <city>Padua</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hochgebirgsklinik Davos</name>
      <address>
        <city>Davos Wolfgang</city>
        <zip>7265</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
    <country>Italy</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2012</study_first_submitted>
  <study_first_submitted_qc>February 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2012</study_first_posted>
  <last_update_submitted>January 15, 2015</last_update_submitted>
  <last_update_submitted_qc>January 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Allergy</keyword>
  <keyword>Egg</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

